Page last updated: 2024-10-15

cgp 43902a

Cross-References

ID SourceID
PubMed CID135430705
CHEMBL ID311929
MeSH IDM0180067

Synonyms (11)

Synonym
CHEMBL311929
cgp 43902a
cgp43902a
cgp-43902a
l 2-9
1-(n-ethoxycarbonylmethylpyridoxylidenium)-2-(2'-pyridyl)hydrazine
l2-9
pyridinium, 1-(2-ethoxy-2-oxoethyl)-3-hydroxy-5-(hydroxymethyl)-2-methyl-4-((2-pyridinylhydrazono)methyl)-, bromide
l-2-9
124076-31-9
AKOS040751106
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID197964Activity against metalloenzyme Ribonucleoside diphosphate reductase was evaluated from a subcutaneously growing murine tumor (sarcoma 180) implanted in B6D2F3 male mice at 1.0 conc1999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerations.
AID197973Inhibition of metalloenzyme Ribonucleoside diphosphate reductase.1999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]